What Virginia Medicaid actually covers for Wegovy, Zepbound, Ozempic and Mounjaro. Most state Medicaid programs still exclude weight-loss-indication GLP-1, but the diabetes path is covered nearly everywhere with prior authorization (your doctor asks the plan to approve it first). Here is the current 2026 reality for Virginia.
Coverage summary
| Indication | Coverage |
|---|---|
| Wegovy (weight loss) | Limited |
| Zepbound (weight loss) | Limited |
| Ozempic / Mounjaro (type 2 diabetes) | Yes |
| Compounded semaglutide / tirzepatide | No |
Prior-authorization criteria
These rules come from the state preferred drug list (PDL), the list of drugs Virginia Medicaid has agreed to pay for.
| Criterion | Value |
|---|---|
| PA burden | High |
| BMI threshold (weight-loss path) | BMI over 40 on its own, or BMI over 37 with a qualifying weight-related condition |
| Comorbidity required | Only for the BMI 37 to 40 range |
| Last PDL update reviewed | 2026-07-01 |
What this means in practice
Virginia Medicaid covers Wegovy and Zepbound for weight loss. The BMI rule effective July 1, 2026 is over 40 on its own. At over 37 you also qualify if you have high cholesterol, high blood pressure or type 2 diabetes. Virginia calls the approval step service authorization. Other states call the same thing prior authorization, and your doctor files it.
Managed-care organizations in Virginia (6 contracted)
Virginia Medicaid contracts with the following managed-care organizations (MCOs), the private health plans the state pays to run day-to-day Medicaid coverage. MCO formularies must meet or exceed the state PDL but can layer in additional criteria. Verify your assigned MCO's most recent PA policy before submitting.
- Anthem HealthKeepers Plus
- Sentara Community Plan
- Aetna Better Health Virginia
- Molina Complete Care
- UnitedHealthcare Community Plan
- Optima Family Care
Cash-pay alternatives if Medicaid does not cover you
If you end up paying cash, the GLP-1 cost guide breaks down what every legitimate path actually costs at maintenance dose, from the $149-a-month compounded floor to branded manufacturer-direct pricing. For ranked cash-pay options, see programs ranked by price and programs under $150 a month. Manufacturer savings cards and patient-assistance programs are not routes here: federal law bars the cards for anyone on Medicaid, and the free-drug programs require being uninsured.
Two routes sit outside Medicaid entirely. If a supply gap rather than cost is blocking your refill, the GLP-1 shortage tracker shows which formulations the FDA lists as in shortage now. And if you are 65 or older and also have Medicare, the senior GLP-1 hub lays out the Medicare coverage paths for dual-eligible patients.
For the full cash-pay picture specific to Virginia, including which programs serve Virginia residents and the Virginia Medicaid cost comparison, see the cheapest GLP-1 in Virginia guide.
Take it to your prescriber: PA letter library
If you qualify under one of the covered indications above, the prior-authorization route is the cheapest path. We maintain a PA letter library with templates for Aetna, Cigna, UnitedHealthcare, Anthem BCBS, Kaiser, Humana, Tricare, FEHB and Medicare Advantage, cross-indexed against six qualifying clinical pictures. Each template cites the plan's policy document, the qualifying ICD-10 codes and the registration-trial evidence.
If you have type 2 diabetes plus chronic kidney disease and established cardiovascular disease, the triple-indication evidence stack (FLOW + SELECT + SUSTAIN-6) is the strongest PA path in any state.
If your PA is denied, the appeal letter library has denial-specific templates. For the commercial and Medicare coverage paths, see the GLP-1 insurance guide.
Virginia Medicaid GLP-1 FAQ
Does Virginia Medicaid cover Wegovy for weight loss?
Does Virginia Medicaid cover Zepbound for weight loss?
Does Virginia Medicaid cover Ozempic or Mounjaro for diabetes?
What if Virginia Medicaid does not cover my GLP-1?
Other state Medicaid pages
See the full 51-state coverage table for the side-by-side view across every US state.
How we built this page
Compiled from each state Medicaid's published preferred drug list, PA criteria and PDL committee minutes. State Medicaid programs are not federally required to cover obesity drugs; the diabetes indication is covered nearly everywhere with PA. State-level data is point-in-time and shifts each PDL cycle. Always verify with your state Medicaid plan before relying on this page.
Last updated: 2026-07-20. We check each state Medicaid PDL and PA criteria quarterly. If you have recently had a different experience with Virginia Medicaid, email hello@glpchart.com with the details and we will check it.
